---
title: "KWON PAUL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/87e01d68-da00-50de-8adc-e9cb564dc9e3
json: https://whiteintel.dev/api/public/dossier/87e01d68-da00-50de-8adc-e9cb564dc9e3
identifier: sec:0001727717
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KWON PAUL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001727717`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/87e01d68-da00-50de-8adc-e9cb564dc9e3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/87e01d68-da00-50de-8adc-e9cb564dc9e3  

## Ownership & control

### Holdings / subsidiaries

- **VYNE Therapeutics Inc.** (officer) — https://whiteintel.dev/entity/d382a860-279d-5548-a93d-0f56d28acd45

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KWON PAUL**. Human view: https://whiteintel.dev/entity/87e01d68-da00-50de-8adc-e9cb564dc9e3 · Structured JSON: https://whiteintel.dev/api/public/dossier/87e01d68-da00-50de-8adc-e9cb564dc9e3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._